Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 3
2015 2
2016 2
2017 4
2018 4
2019 5
2020 5
2021 4
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all Quoted phrase not found in phrase index: "infection"
Page 1
A basic review on systemic treatment options in WHO grade II-III gliomas.
Mair MJ, Geurts M, van den Bent MJ, Berghoff AS. Mair MJ, et al. Among authors: geurts m. Cancer Treat Rev. 2021 Jan;92:102124. doi: 10.1016/j.ctrv.2020.102124. Epub 2020 Nov 13. Cancer Treat Rev. 2021. PMID: 33227622 Free article. Review.
WHO grade II-III gliomas are rare primary brain tumors occurring at a median age of about 35-55 years. Median survival is longer in WHO grade II-III glioma compared with WHO grade IV glioblastoma as survival times of up to 10 years and longer can be observed. ...The …
WHO grade II-III gliomas are rare primary brain tumors occurring at a median age of about 35-55 years. Median survival is longer in WHO grad …
Treatment of anaplastic gliomas: evidences and controversies.
Geurts M, Snijders TJ, van den Bent MJ. Geurts M, et al. Curr Opin Oncol. 2021 Nov 1;33(6):621-625. doi: 10.1097/CCO.0000000000000785. Curr Opin Oncol. 2021. PMID: 34456249 Review.
RECENT FINDINGS: New biomarkers allow the identification of anaplastic glioma with relatively poor prognosis and with prognosis similar to glioblastoma. ...A recent study shows that even in selected patients with anaplastic glioma with foci of malignant tumor …
RECENT FINDINGS: New biomarkers allow the identification of anaplastic glioma with relatively poor prognosis and with prognosis simil …
Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis.
Geurts M, Macleod MR, Kollmar R, Kremer PH, van der Worp HB. Geurts M, et al. Crit Care Med. 2014 Feb;42(2):231-42. doi: 10.1097/CCM.0b013e3182a276e8. Crit Care Med. 2014. PMID: 23989182 Review.
STUDY SELECTION: We included randomized controlled clinical trials of therapeutic hypothermia induced in adults for any indication, which reported the prevalence of infection in each treatment group. DATA EXTRACTION: For each study, we collected information about the basel …
STUDY SELECTION: We included randomized controlled clinical trials of therapeutic hypothermia induced in adults for any indication, which re …
Quality of dying after acute stroke.
Reinink H, Geurts M, Melis-Riemens C, Hollander A, Kappelle J, van der Worp B. Reinink H, et al. Among authors: geurts m. Eur Stroke J. 2021 Sep;6(3):268-275. doi: 10.1177/23969873211041843. Epub 2021 Sep 5. Eur Stroke J. 2021. PMID: 34746423 Free PMC article.
INTRODUCTION: There is a lack of evidence concerning the palliative needs of patients with acute stroke during end-of-life care. We interviewed relatives of patients who deceased in our stroke unit about the quality of dying and compared their experiences with those …
INTRODUCTION: There is a lack of evidence concerning the palliative needs of patients with acute stroke during end-of-life care. We i …
Treatment Restrictions and the Risk of Death in Patients With Ischemic Stroke or Intracerebral Hemorrhage.
Reinink H, Konya B, Geurts M, Kappelle LJ, van der Worp HB. Reinink H, et al. Among authors: geurts m. Stroke. 2020 Sep;51(9):2683-2689. doi: 10.1161/STROKEAHA.120.029788. Epub 2020 Aug 6. Stroke. 2020. PMID: 32757755
BACKGROUND AND PURPOSE: Do-not-resuscitate (DNR) orders in the first 24 hours after intracerebral hemorrhage have been associated with an increased risk of early death. This relationship is less certain for ischemic stroke. We assessed the relation between treatment restri …
BACKGROUND AND PURPOSE: Do-not-resuscitate (DNR) orders in the first 24 hours after intracerebral hemorrhage have been associated with an in …
Immunotherapy in Glioblastoma: Current Shortcomings and Future Perspectives.
Weenink B, French PJ, Sillevis Smitt PAE, Debets R, Geurts M. Weenink B, et al. Among authors: geurts m. Cancers (Basel). 2020 Mar 22;12(3):751. doi: 10.3390/cancers12030751. Cancers (Basel). 2020. PMID: 32235752 Free PMC article.
In this perspective, we provide an overview of immune interventions performed to date in glioblastoma patients and re-evaluate their performance. We argue that shortcomings of current immune therapies in glioblastoma are related to three major determinants of resist …
In this perspective, we provide an overview of immune interventions performed to date in glioblastoma patients and re-evaluate their …
Adverse prognosis of glioblastoma contacting the subventricular zone: Biological correlates.
Berendsen S, van Bodegraven E, Seute T, Spliet WGM, Geurts M, Hendrikse J, Schoysman L, Huiszoon WB, Varkila M, Rouss S, Bell EH, Kroonen J, Chakravarti A, Bours V, Snijders TJ, Robe PA. Berendsen S, et al. Among authors: geurts m. PLoS One. 2019 Oct 11;14(10):e0222717. doi: 10.1371/journal.pone.0222717. eCollection 2019. PLoS One. 2019. PMID: 31603915 Free PMC article.
INTRODUCTION: The subventricular zone (SVZ) in the brain is associated with gliomagenesis and resistance to treatment in glioblastoma. In this study, we investigate the prognostic role and biological characteristics of subventricular zone (SVZ) involvement in glioblasto …
INTRODUCTION: The subventricular zone (SVZ) in the brain is associated with gliomagenesis and resistance to treatment in glioblastoma …
A Novel miR-146a-POU3F2/SMARCA5 Pathway Regulates Stemness and Therapeutic Response in Glioblastoma.
Cui T, Bell EH, McElroy J, Liu K, Sebastian E, Johnson B, Gulati PM, Becker AP, Gray A, Geurts M, Subedi D, Yang L, Fleming JL, Meng W, Barnholtz-Sloan JS, Venere M, Wang QE, Robe PA, Haque SJ, Chakravarti A. Cui T, et al. Among authors: geurts m. Mol Cancer Res. 2021 Jan;19(1):48-60. doi: 10.1158/1541-7786.MCR-20-0353. Epub 2020 Sep 24. Mol Cancer Res. 2021. PMID: 32973101
Rapid tumor growth, widespread brain-invasion, and therapeutic resistance critically contribute to glioblastoma (GBM) recurrence and dismal patient outcomes. Although GBM stem cells (GSC) are shown to play key roles in these processes, the molecular pathways governing the …
Rapid tumor growth, widespread brain-invasion, and therapeutic resistance critically contribute to glioblastoma (GBM) recurrence and …
27 results